209 related articles for article (PubMed ID: 23282402)
1. Bradykinin and the pathogenesis of hereditary angioedema.
Kaplan AP
World Allergy Organ J; 2011 Apr; 4(4):73-5. PubMed ID: 23282402
[No Abstract] [Full Text] [Related]
2. HAE Pathophysiology and Underlying Mechanisms.
Zuraw BL; Christiansen SC
Clin Rev Allergy Immunol; 2016 Oct; 51(2):216-29. PubMed ID: 27459852
[TBL] [Abstract][Full Text] [Related]
3. [Bradykinin-induced angioedema: Definition, pathogenesis, clinical presentation, diagnosis and therapy].
Hahn J; Bas M; Hoffmann TK; Greve J
HNO; 2015 Dec; 63(12):885-93; quiz 894-5. PubMed ID: 26597136
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
Bork K; Frank J; Grundt B; Schlattmann P; Nussberger J; Kreuz W
J Allergy Clin Immunol; 2007 Jun; 119(6):1497-503. PubMed ID: 17418383
[TBL] [Abstract][Full Text] [Related]
5. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
6. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
Bartal C; Zeldetz V; Stavi V; Barski L
Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
[TBL] [Abstract][Full Text] [Related]
7. Hereditary angioedema: Looking for bradykinin production and triggers of vascular permeability.
Margaglione M; D'Apolito M; Santocroce R; Maffione AB
Clin Exp Allergy; 2019 Nov; 49(11):1395-1402. PubMed ID: 31574187
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].
Muller Y; Harr T
Rev Med Suisse; 2016 Jan; 12(500):11-2. PubMed ID: 26946694
[TBL] [Abstract][Full Text] [Related]
9. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
10. Hereditary angioedema: a disease seldom diagnosed by pediatricians.
Campos RA; Valle SOR; Toledo EC
J Pediatr (Rio J); 2021; 97 Suppl 1(Suppl 1):S10-S16. PubMed ID: 33271064
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitor-induced angioedema: epidemiology, pathogenesis and management.
Sobotková M
Vnitr Lek; 2018; 64(10):928-933. PubMed ID: 30590939
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade.
Kaplan AP; Joseph K
Immunol Allergy Clin North Am; 2017 Aug; 37(3):513-525. PubMed ID: 28687106
[TBL] [Abstract][Full Text] [Related]
13. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade.
Busse P; Kaplan A
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):716-722. PubMed ID: 34838707
[TBL] [Abstract][Full Text] [Related]
14. Novelties in the Diagnosis and Treatment of Angioedema.
Cicardi M; Suffritti C; Perego F; Caccia S
J Investig Allergol Clin Immunol; 2016; 26(4):212-21; quiz two pages after page 221. PubMed ID: 27470642
[TBL] [Abstract][Full Text] [Related]
15. Angioedema Due to Bradykinin Dysregulation.
Cicardi M; Zuraw BL
J Allergy Clin Immunol Pract; 2018; 6(4):1132-1141. PubMed ID: 30033914
[TBL] [Abstract][Full Text] [Related]
16. Angioedema with severe acute abdominal pain: Think of hereditary angioedema.
Mumneh N; Tick M; Borum M
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101702. PubMed ID: 33864899
[TBL] [Abstract][Full Text] [Related]
17. Does hereditary angioedema make COVID-19 worse?
Xu Y; Liu S; Zhang Y; Zhi Y
World Allergy Organ J; 2020 Sep; 13(9):100454. PubMed ID: 32834893
[TBL] [Abstract][Full Text] [Related]
18. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations.
Caballero T; Baeza ML; Cabañas R; Campos A; Cimbollek S; Gómez-Traseira C; González-Quevedo T; Guilarte M; Jurado-Palomo J; Larco JI; López-Serrano MC; López-Trascasa M; Marcos C; Muñoz-Caro JM; Pedrosa M; Prior N; Rubio M; Sala-Cunill A;
J Investig Allergol Clin Immunol; 2011; 21(6):422-41; quiz 442-3. PubMed ID: 21995176
[TBL] [Abstract][Full Text] [Related]
19. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.
Cicardi M; Banerji A; Bracho F; Malbrán A; Rosenkranz B; Riedl M; Bork K; Lumry W; Aberer W; Bier H; Bas M; Greve J; Hoffmann TK; Farkas H; Reshef A; Ritchie B; Yang W; Grabbe J; Kivity S; Kreuz W; Levy RJ; Luger T; Obtulowicz K; Schmid-Grendelmeier P; Bull C; Sitkauskiene B; Smith WB; Toubi E; Werner S; Anné S; Björkander J; Bouillet L; Cillari E; Hurewitz D; Jacobson KW; Katelaris CH; Maurer M; Merk H; Bernstein JA; Feighery C; Floccard B; Gleich G; Hébert J; Kaatz M; Keith P; Kirkpatrick CH; Langton D; Martin L; Pichler C; Resnick D; Wombolt D; Fernández Romero DS; Zanichelli A; Arcoleo F; Knolle J; Kravec I; Dong L; Zimmermann J; Rosen K; Fan WT
N Engl J Med; 2010 Aug; 363(6):532-41. PubMed ID: 20818888
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin-mediated angioedema.
Obtułowicz K
Pol Arch Med Wewn; 2016; 126(1-2):76-85. PubMed ID: 26842379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
